AIKIDO PHARMA INC (AIKI) Stock Analyst Ratings
USA - NASDAQ:AIKI - US0088753043 - Common Stock
3.56 USD
+0.01 (+0.28%)
ChartMill assigns a Buy % Consensus number of 83% to AIKI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.32. This target is 358.43% above the current price.
AIKI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about AIKI.
In the previous month the buy percentage consensus was at a similar level.
AIKI was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-11 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-11 | HC Wainwright & Co. | Initiate | Buy |
AIKIDO PHARMA INC / AIKI FAQ
What is the price target for AIKI stock?
7 analysts have analysed AIKI and the average price target is 16.32 USD. This implies a price increase of 358.43% is expected in the next year compared to the current price of 3.56.
What is the consensus rating for AIKIDO PHARMA INC (AIKI) stock?
The consensus rating for AIKIDO PHARMA INC (AIKI) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for AIKI stock?
The number of analysts covering AIKIDO PHARMA INC (AIKI) is 7.